Tarsons Products Limited (NSE:TARSONS)
196.72
-2.92 (-1.46%)
Feb 19, 2026, 2:08 PM IST
Tarsons Products Market Cap
Tarsons Products has a market cap or net worth of 10.62 billion as of February 18, 2026. Its market cap has decreased by -45.24% in one year.
Market Cap
10.62B
Enterprise Value
14.27B
Revenue
4.14B
Ranking
n/a
PE Ratio
52.16
Stock Price
196.72
Market Cap Chart
Since November 26, 2021, Tarsons Products's market cap has decreased from 43.54B to 10.62B, a decrease of -75.61%. That is a compound annual growth rate of -28.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 10.62B | -14.43% |
| Dec 31, 2025 | 12.41B | -42.20% |
| Dec 31, 2024 | 21.48B | -24.21% |
| Dec 29, 2023 | 28.34B | -23.31% |
| Dec 30, 2022 | 36.95B | 7.67% |
| Dec 31, 2021 | 34.32B | -21.19% |
| Nov 26, 2021 | 43.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.14T |
| Divi's Laboratories | 1.64T |
| Apollo Hospitals Enterprise | 1.10T |
| Cipla | 1.09T |
| Ind-Swift Laboratories | 11.72B |
| Jagsonpal Pharmaceuticals | 11.68B |
| Beta Drugs | 11.27B |
| Sakar Healthcare | 10.59B |